Key Takeaways Stem cells for psoriasis remain experimental, and the human evidence comes from very small studies. Cochrane’s living review found that biologic medicines cleared skin better than older tablets across 204 studies. A 2022 trial of 17 people found 8 had at least 40% skin improvement after cord cell
Key Takeaways Stem cell therapy for rheumatoid arthritis has real human trial data behind it, not just lab or animal studies. A 3-year study found that disease activity scores significantly decreased in patients who received stem cells alongside standard medication. Mesenchymal stem cells appear to calm the immune response that
Key Takeaways Stem cell therapy for psoriasis is being studied for its ability to calm the immune system, not just treat visible skin symptoms. Mesenchymal stem cells appear to shift the balance between two immune cell types, easing the overactive response behind psoriasis. A real phase 1/2a human trial using
Key Takeaways Stem cell treatment for ulcerative colitis targets the immune dysfunction at the root of the disease, not just the symptoms in the colon and rectum. Mesenchymal stem cells MSCs reduce harmful immune responses, expand regulatory T cells, and release growth factors that support mucosal healing and tissue regeneration.
Key Takeaways Umbilical cord derived mesenchymal stem cells (UC-MSCs) are a well-studied source of MSC therapy for ulcerative colitis UC, with strong anti-inflammatory and tissue repair properties. UC-MSCs home to inflamed tissue, calm overactive immune cells, and promote macrophage repolarisation from a damaging M1 state to a healing M2 state.
